Tumour-autonomous IL-6 signalling creates a metabolic vulnerability in intrahepatic cholangiocarcinoma. Cubero FJ, Macias RIR. Gut 2026 May 4:gutjnl-2026-338744. doi: 10.1136/gutjnl-2026-338744.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cubero FJ, Macias RIR. Tumour-autonomous IL-6 signalling creates a metabolic vulnerability in intrahepatic cholangiocarcinoma. Gut 2026 May 4:gutjnl-2026-338744. doi: 10.1136/gutjnl-2026-338744.
PMID: 42082332